Simon Leveille
Affiliations: | 2012 | Microbiology | McGill University, Montreal, QC, Canada |
Google:
"Simon Leveille"Mean distance: 26716.5 (cluster 18)
Parents
Sign in to add mentor| John Hiscott | grad student | 2012 | McGill | |
| (Combination strategies in the development of oncolytic virus cancer therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Leveille S, Goulet ML, Lichty BD, et al. (2011) Vesicular stomatitis virus oncolytic treatment interferes with tumor-associated dendritic cell functions and abrogates tumor antigen presentation. Journal of Virology. 85: 12160-9 |
| Leveille S, Samuel S, Goulet ML, et al. (2011) Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy. Cancer Gene Therapy. 18: 435-43 |
| Nguyên TL, Abdelbary H, Arguello M, et al. (2008) Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proceedings of the National Academy of Sciences of the United States of America. 105: 14981-6 |
| Leveille S, Hiscott J. (2008) 345 Gentically engineered oncolytic vesicular stomatitis virus to stimulate anti-tumor immune response Cytokine. 43: 325 |
| Nakhaei P, Mesplède T, Sun Q, et al. (2008) 10 X-linked inhibitor of apoptosis protein inhibits RIG-I signalling pathway Cytokine. 43: 239 |
| Holm GH, Zurney J, Tumilasci V, et al. (2007) Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. The Journal of Biological Chemistry. 282: 21953-61 |